Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, is an India-based developer and manufacturer of non-commoditized, active pharmaceutical ingredients (APIs) in chronic ...
In 2001, Glenmark Pharmaceuticals established its API business. The first product registered with USFDA in 2003. The Company acquired Glaxo SmithKlines (GSK) API manufacturing plant in Ankleshwar ...
Three new pharmaceutical modules became fully operational at its Ankleshwar facility.During the year 2022-23, in the Respiratory segment, Glenmark became the first company in India to market ...
Read also: Glenmark Pharma USA unveils Lacosamide Oral Solution The official ... The company’s 4 manufacturing facilities are located in Ankleshwar, Dahej, Mohol and Kurkumbh with a total installed ...
Drug maker Glenmark Pharmaceuticals Ltd has received a demand notice of Rs 121.25 crore, seeking tax, interest, and penalties from the Joint Commissioner of Central Goods and Services Tax and ...
Cosmo CEO Giovanni Di Napoli said the milestone underscores the company's commitment, alongside Glenmark, to provide patients ...
The Subject Expert Committee (SEC), which advises the Central drug regulator, has recommended grant of permission to Glenmark Pharmaceuticals to import and market cancer drug tislelizumab injection in ...
Over 100 personnel with Glenmark Pharmaceuticals’ consumer care division have been retrenched, according to an industry source. The sales personnel were from across the country, and according to ...
Glenmark Life Sciences, a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas, announces its change of ...
Glenmark Pharmaceuticals Ltd was incorporated in November 18th 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results